Indivior Pharmaceuticals Inc
(INDV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | ||||
| Net Income | 327,000 | 695,000 | 884,000 | 872,000 |
| Depreciation Amortization | 13,000 | 28,000 | 27,000 | 25,000 |
| Accounts receivable | -4,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -20,000 | N/A | N/A | N/A |
| Other Working Capital | -24,000 | 134,000 | -37,000 | -101,000 |
| Other Operating Activity | -1,000 | -66,000 | -8,000 | -81,000 |
| Operating Cash Flow | $291,000 | $791,000 | $866,000 | $715,000 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,000 | -3,000 | -3,000 | -4,000 |
| Purchase Sale Intangibles | -24,000 | N/A | N/A | N/A |
| Other Investing Activity | -24,000 | 0 | 0 | -21,000 |
| Investing Cash Flow | $-25,000 | $-3,000 | $-3,000 | $-25,000 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | -262,000 | -806,000 | -845,000 | -697,000 |
| Financing Cash Flow | $-262,000 | $-806,000 | $-845,000 | $-697,000 |
| Beginning Cash Position | 7,000 | 25,000 | 7,000 | 14,000 |
| End Cash Position | 11,000 | 7,000 | 7,000 | 12,000 |
| Net Cash Flow | $4,000 | $-18,000 | $18,000 | $-7,000 |
| Free Cash Flow | ||||
| Operating Cash Flow | 291,000 | 791,000 | 866,000 | 715,000 |
| Capital Expenditure | -1,000 | N/A | N/A | N/A |
| Free Cash Flow | 290,000 | 791,000 | 866,000 | 715,000 |